Program


The 2019 program will consist of the following sessions.

  • capacity-building sessions,
  • state-of-the-art lectures,
  • debates,
  • panel discussion sessions,
  • abstract presentations,
  • poster discussion sessions,
  • guided poster walks, and
  • poster viewing sessions.

CONFIRMED SPEAKERS

Opening session: Transition to domestic/regional funds
 
  • The UNAIDS perspective - Eamonn Murphy, UNAIDS Asia and the Pacific
  • Transitioning from international to domestic funding: Experiences in the Asia Pacific - Ravipa Vannakit, USAID Regional Development Mission for Asia, Thailand
 
Progress in HIV Cure/ Elimination
  • Introduction to HIV persistence on ART - Denise Hsu, US Military HIV Research Program, Thailand
  • Overview of clinical trials for HIV cure - James McMahon, Monash University, Australia
 
Key populations and power
  • Key Population community engagement - Matthew Avery, FHI 360, Thailand
  • Key pop-led HIV service delivery: focus on transgenders - Rena Janamnuaysook, Thai Red Cross AIDS Research Centre, Thailand
  • BlueD experience with empowering MSM in the HIV response - Dapeng Zhang, BlueD, China
 
HIV-TB, fungal, and other OIs 
  • Prevention of cryptococcosis and other AIDS-related fungal infections: strategies for the Asia Pacific region - David Boulware, University of Minnesota, USA
 
Viral hepatitis and sexually transmitted infections
  • Hepatitis B therapy pipeline: How far are we from cure - Peter Revill, Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Australia
  • Epidemic of acute HCV: What have we learned? - Chien-Ching Hung, National Taiwan University Hospital, Taiwan
 
PrEP - demedicalization
  • Provider's perspective of PrEP demedicalization - Heather-Marie Schmidt, UNAIDS Asia Pacific Regional Support Team and the World Health Organisation, Thailand 
  • Community perspective of demedicalization of PrEP - Danvic Rosadiño, LoveYourself, Philippines 
  • The use of technology to demedicalize PrEP - Rena Janamnuaysook, Thai Red Cross AIDS Research Centre, Thailand
 

Debate session

Same-day ART should be implemented in HIV treatment programs in the Asia-Pacific
  • Pro standpoint - Iskandar Azwa, University of Malaya, Malaysia
  • Con standpoint - Edsel Salvana, University of the Philippines Manila, the Philippines

Capacity-building sessions

Critical reading/ bias in clinical research

Dr Matthew Law and Dr Awachana Jiamsakul, The Kirby Institute, UNSW Sydney

This session will focus on how to evaluate biases and weaknesses in different types of epidemiological studies, such as cohort vs case-control studies, and will provide participants with knowledge of how to handle critical data issues such as the presence of missing data. These skills will enable participants to critically appraise and make informed decisions when reviewing a scientific research article.
 
Preparing for publication in Lancet journals
Richard Henderson, Senior Editor, Lancet in HIV
 
Richard Henderson will give an overview of the reporting guidelines for the different study types and the essential elements of a successful submission for Lancet journals. Topics covered will include what editors look for, authorship, paper structure, submission and peer review, conflicts of interest, and referencing.
 
Online clinical management tools
Dr Jonathan Schapiro, Sheba Medical Centre and Dr Saye Khoo, University of Liverpool
 
HIV dedicated websites and Apps can assist clinicians in the routine care of patients. Two of these commonly used include The Stanford University HIV Drug Resistance Database (hivdb.stanford.edu) and the University of Liverpool HIV Drug Interactions Website and App (hiv-druginteractions.org). Jonathan Schapiro and Saye Khoo will provide a workshop style interactive capacity building session focused on assisting clinicians in integrating these tools into their routine practice.